BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25867817)

  • 1. iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation.
    Cheng PP; Liu XC; Ma PF; Gao C; Li JL; Lin YY; Shao W; Han S; Zhao B; Wang LM; Fu JZ; Meng LX; Li Q; Lian QZ; Xia JJ; Qi ZQ
    Stem Cells Dev; 2015 Aug; 24(15):1793-804. PubMed ID: 25867817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases.
    Li CL; Leng Y; Zhao B; Gao C; Du FF; Jin N; Lian QZ; Xu SY; Yan GL; Xia JJ; Zhuang GH; Fu QL; Qi ZQ
    Stem Cells; 2017 Jul; 35(7):1719-1732. PubMed ID: 28520232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells in combination with low-dose rapamycin significantly prolong islet allograft survival through induction of regulatory T cells.
    Duan W; Yu X; Ma D; Yang B; Li Y; Huang L; Liu L; Chen G; Xu D; Ding Y
    Biochem Biophys Res Commun; 2018 Nov; 506(3):619-625. PubMed ID: 30454697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iPSC-MSCs and islet allograft tolerance.
    Wang TS; Cheng PP; Qi ZQ
    Oncotarget; 2015 May; 6(13):10669-70. PubMed ID: 26027882
    [No Abstract]   [Full Text] [Related]  

  • 5. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
    Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
    Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants.
    Khan MA; Alanazi F; Ahmed HA; Shamma T; Kelly K; Hammad MA; Alawad AO; Assiri AM; Broering DC
    Stem Cell Res Ther; 2019 Sep; 10(1):290. PubMed ID: 31547869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model.
    Jia Z; Jiao C; Zhao S; Li X; Ren X; Zhang L; Han ZC; Zhang X
    Exp Eye Res; 2012 Sep; 102():44-9. PubMed ID: 22800963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation.
    Yoshida S; Miyagawa S; Toyofuku T; Fukushima S; Kawamura T; Kawamura A; Kashiyama N; Nakamura Y; Toda K; Sawa Y
    Sci Rep; 2020 Mar; 10(1):4593. PubMed ID: 32165680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined intrathymic and intravenous injection of mesenchymal stem cells can prolong the survival of rat cardiac allograft associated with decrease in miR-155 expression.
    Huang H; He J; Teng X; Yu Y; Ye W; Hu Y; Shen Z
    J Surg Res; 2013 Dec; 185(2):896-903. PubMed ID: 23870834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tolerance and prolongation of islet allograft survival by syngeneic hematopoietic stem cell transplantation in mice.
    Yang SF; Xue WJ; Lu WH; Xie LY; Yin AP; Zheng J; Sun JP; Li Y
    Transpl Immunol; 2015 Oct; 33(2):130-9. PubMed ID: 26311302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts.
    Kim YH; Wee YM; Choi MY; Lim DG; Kim SC; Han DJ
    Mol Med; 2011; 17(7-8):697-708. PubMed ID: 21365122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.
    Kim KW; Moon SJ; Park MJ; Kim BM; Kim EK; Lee SH; Lee EJ; Chung BH; Yang CW; Cho ML
    Stem Cell Res Ther; 2015 Oct; 6():202. PubMed ID: 26497134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Dose Interleukin-2 Combined With Rapamycin Led to an Expansion of CD4
    Hu M; Hawthorne WJ; Nicholson L; Burns H; Qian YW; Liuwantara D; Jimenez Vera E; Chew YV; Williams L; Yi S; Keung K; Watson D; Rogers N; Alexander SI; O'Connell PJ
    Diabetes; 2020 Aug; 69(8):1735-1748. PubMed ID: 32381646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-9 in combination with rapamycin induces cardiac allograft tolerance in mice.
    Cai L; Zhou H; Fang Z; Yuan J; Niki T; Hirashima M; He W; Chen ZK
    Transplantation; 2013 Aug; 96(4):379-86. PubMed ID: 23838998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Results in Downregulation of c-Myc and DNA Replication Pathways with Immunomodulation Toward CD4 and CD8 Cells.
    Wang LT; Jiang SS; Ting CH; Hsu PJ; Chang CC; Sytwu HK; Liu KJ; Yen BL
    Stem Cells; 2018 Jun; 36(6):903-914. PubMed ID: 29396902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination regimen of low-dose bortezomib and rapamycin prolonged the graft survival in a murine allogeneic islet transplantation model.
    Hong SH; Kim K; Shin JS; Chung H; Park CG
    Immunol Lett; 2019 Dec; 216():21-27. PubMed ID: 31593743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.
    Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K
    Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
    Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A
    Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism of a natural plant product, oleanolic acid with calcineurin inhibitor in prolonging islet allograft survival.
    Angaswamy N; Tiriveedhi V; Banan B; Benshoff N; Chapman W; Mohanakumar T
    Transpl Immunol; 2013 Dec; 29(1-4):64-70. PubMed ID: 24036218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.